Monica Gandhi1, Sarita Devi2, Peter Bacchetti3, Sara Chandy4, Elsa Heylen5, Nhi Phung1, Karen Kuncze1, Hideaki Okochi6, Ravi Kumar7, Anura V Kurpad2, Maria L Ekstrand4,5. 1. Division of HIV, Infectious Disease and Global Medicine, Department of Medicine, University of California, San Francisco (UCSF), San Francisco, CA. 2. Department of Physiology, St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India. 3. Department of Epidemiology and Biostatistics, University of California, San Francisco (UCSF), San Francisco, CA. 4. Department of Medicine, St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India. 5. Center for AIDS Prevention Studies, Department of Medicine, University of California, San Francisco (UCSF), San Francisco, CA. 6. Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF), San Francisco, CA. 7. Karnataka State AIDS Prevention Society, Bangalore, India.
Abstract
BACKGROUND: Objective adherence measures are of increasing interest in antiretroviral treatment (ART) monitoring. Hair ART levels predict virologic suppression, and hair is easy to collect and store. No previous study has examined hair levels in an India-based cohort or laboratory. METHODS: Small hair samples were collected from HIV-positive participants on either efavirenz (EFV)-based or nevirapine (NVP)-based ART in a South India-based study. Hair samples were split and analyzed for EFV or NVP in the University of California, San Francisco -based Hair Analytical Laboratory and the analytic laboratory of the Division of Nutrition at St. John's Research Institute, Bangalore, India, using liquid chromatography/tandem mass spectrometry. Agreement (using Bland-Altman methods) and rank correlation between the 2 laboratories' hair levels were calculated. Rank correlation between self-reported adherence (SRA) over the previous month using a visual analog scale and hair ART levels was calculated. RESULTS: Among 75 participants (38 on NVP; 37 on EFV), the correlation between NVP levels generated by the 2 laboratories was 0.66 (P < 0.0001) and between EFV levels was 0.87 (P < 0.0001). Measurements from St. John's Research Institute were usually within 20% of those from the University of California, San Francisco Hair Analytical Laboratory. SRA was essentially uncorrelated with hair antiretroviral levels for either drug (all correlations < 0.04). Hair levels showed variability in adherence although SRA was >85% in all participants. CONCLUSIONS: Hair ART levels measured by both an India-based laboratory and the standard U.S.-based laboratory showed generally high agreement and correlation, demonstrating local capacity. As in many other cohorts, hair ART levels and SRA were not well-correlated, likely indicating limitations in self-report and the need for objective adherence monitoring in resource-limited settings.
BACKGROUND: Objective adherence measures are of increasing interest in antiretroviral treatment (ART) monitoring. Hair ART levels predict virologic suppression, and hair is easy to collect and store. No previous study has examined hair levels in an India-based cohort or laboratory. METHODS: Small hair samples were collected from HIV-positive participants on either efavirenz (EFV)-based or nevirapine (NVP)-based ART in a South India-based study. Hair samples were split and analyzed for EFV or NVP in the University of California, San Francisco -based Hair Analytical Laboratory and the analytic laboratory of the Division of Nutrition at St. John's Research Institute, Bangalore, India, using liquid chromatography/tandem mass spectrometry. Agreement (using Bland-Altman methods) and rank correlation between the 2 laboratories' hair levels were calculated. Rank correlation between self-reported adherence (SRA) over the previous month using a visual analog scale and hair ART levels was calculated. RESULTS: Among 75 participants (38 on NVP; 37 on EFV), the correlation between NVP levels generated by the 2 laboratories was 0.66 (P < 0.0001) and between EFV levels was 0.87 (P < 0.0001). Measurements from St. John's Research Institute were usually within 20% of those from the University of California, San Francisco Hair Analytical Laboratory. SRA was essentially uncorrelated with hair antiretroviral levels for either drug (all correlations < 0.04). Hair levels showed variability in adherence although SRA was >85% in all participants. CONCLUSIONS: Hair ART levels measured by both an India-based laboratory and the standard U.S.-based laboratory showed generally high agreement and correlation, demonstrating local capacity. As in many other cohorts, hair ART levels and SRA were not well-correlated, likely indicating limitations in self-report and the need for objective adherence monitoring in resource-limited settings.
Authors: Jean B Nachega; Nadia A Sam-Agudu; Lynne M Mofenson; Mauro Schechter; John W Mellors Journal: Clin Infect Dis Date: 2018-05-02 Impact factor: 9.079
Authors: Tariro D Chawana; Monica Gandhi; Kusum Nathoo; Bernard Ngara; Alexander Louie; Howard Horng; David Katzenstein; John Metcalfe; Charles F B Nhachi Journal: J Acquir Immune Defic Syndr Date: 2017-09-01 Impact factor: 3.731
Authors: R DiFrancesco; K Tooley; S L Rosenkranz; S Siminski; C R Taylor; P Pande; G D Morse Journal: Clin Pharmacol Ther Date: 2013-03-26 Impact factor: 6.875
Authors: Yong Huang; Monica Gandhi; Ruth M Greenblatt; Winnie Gee; Emil T Lin; Nicholas Messenkoff Journal: Rapid Commun Mass Spectrom Date: 2008-11 Impact factor: 2.419
Authors: Sanjiv M Baxi; Eric Vittinghoff; Peter Bacchetti; Yong Huang; Kata Chillag; Ryan Wiegand; Peter L Anderson; Robert Grant; Ruth M Greenblatt; Susan Buchbinder; Monica Gandhi; Albert Y Liu Journal: PLoS One Date: 2018-01-09 Impact factor: 3.240
Authors: Monica Gandhi; Peter Bacchetti; Warren C Rodrigues; Matthew Spinelli; Catherine A Koss; Paul K Drain; Jared M Baeten; Nelly R Mugo; Kenneth Ngure; Leslie Z Benet; Hideaki Okochi; Guohong Wang; Michael Vincent Journal: EClinicalMedicine Date: 2018-08-31
Authors: Matthew A Spinelli; Jessica E Haberer; Peter R Chai; Jose Castillo-Mancilla; Peter L Anderson; Monica Gandhi Journal: Curr HIV/AIDS Rep Date: 2020-08 Impact factor: 5.071
Authors: Monica Gandhi; Babafemi Taiwo; Jacinta N Nwogu; Samuel O Ngene; Chinedum P Babalola; Adeniyi Olagunju; Andrew Owen; Saye H Khoo; Olayinka A Kotila; Baiba Berzins; Hideaki Okochi; Regina Tallerico Journal: AIDS Res Ther Date: 2022-07-10 Impact factor: 2.846
Authors: Mira Wang; Joshua D Miller; Shalean M Collins; Marianne V Santoso; Pauline Wekesa; Hideaki Okochi; Maricianah Onono; Sheri Weiser; Monica Gandhi; Sera L Young Journal: AIDS Behav Date: 2020-10
Authors: Monica Gandhi; Guohong Wang; Roger King; Warren C Rodrigues; Michael Vincent; David V Glidden; Tim R Cressey; Peter Bacchetti; Matthew A Spinelli; Hideaki Okochi; Oraphan Siriprakaisil; Virat Klinbuayaem; Nelly R Mugo; Kenneth Ngure; Paul K Drain; Jared M Baeten Journal: AIDS Date: 2020-02-01 Impact factor: 4.632
Authors: Tanakorn Apornpong; Beatriz Grinsztejn; Michael Hughes; Justin Ritz; Stephen J Kerr; Courtney V Fletcher; Kiat Ruxrungtham; Catherine Godfrey; Robert Gross; Evelyn Hogg; Carole L Wallis; Sharlaa Badal-Faesen; Mina C Hosseinipour; Rosie Mngqbisa; Breno R Santos; Sarita Shah; Laura J Hovind; Sajeeda Mawlana; Marije Van Schalkwyk; Nuntisa Chotirosniramit; Cecilia Kanyama; Nagalingeswaran Kumarasamy; Robert Salata; Ann C Collier; Monica Gandhi Journal: AIDS Date: 2021-07-15 Impact factor: 4.632
Authors: Maria L Ekstrand; Elsa Heylen; Matilda Pereira; Sara Chandy; Krishnamachari Srinivasan Journal: J Int Assoc Provid AIDS Care Date: 2022 Jan-Dec
Authors: Ebiere C Herbertson; Cecile D Lahiri; Jacinta N Nwogu; Rebecca O Soremekun; Olubusola A Olugbake; Oliver C Ezechi; Alani S Akanmu; Monica Gandhi Journal: AIDS Res Hum Retroviruses Date: 2021-04-15 Impact factor: 1.723
Authors: Cindy Vavro; Theodore Ruel; Andrew Wiznia; Nicole Montañez; Keith Nangle; Joseph Horton; Ann M Buchanan; Eugene L Stewart; Paul Palumbo Journal: Antimicrob Agents Chemother Date: 2021-10-25 Impact factor: 5.938
Authors: Tanja R Zijp; Zamrotul Izzah; Daan J Touw; Job F M van Boven; Christoffer Åberg; C Tji Gan; Stephan J L Bakker Journal: Drugs Date: 2021-11-01 Impact factor: 9.546